v3.24.1.1.u2
Other equity reserves (Tables)
12 Months Ended
Mar. 31, 2024
Disclosure of reserves within equity [abstract]  
Schedule of reserves within equity
Translation
£m
Cash flow
hedge
£m
Cost of
hedging
£m
FVOCI
equity
£m
FVOCI
debt
£m
Own
credit
£m
Capital
redemption
£m
Merger
£m
Total
£m
At 1 April 2021
(35)
(48)
(28)
51
111
1
19
(5,165)
(5,094)
Exchange adjustments1
629
629
Net losses taken to equity2
(96)
(2)
(70)
(11)
(1)
(180)
Share of net gains of associates taken to equity
1
1
Transferred to profit or loss
40
(1)
39
Net losses in respect of cash flow hedging
of capital expenditure
(1)
(1)
Tax
11
2
19
3
35
Cash flow hedges transferred to the statement
of financial position, net of tax
8
8
At 1 April 2022
594
(85)
(29)
103
19
(5,165)
(4,563)
Exchange adjustments1
882
882
Exchange differences reclassified to the consolidated
income statement on disposal
(170)
(170)
Net gains/(losses) taken to equity
142
(12)
(25)
105
Share of net gains of associates taken to equity
1
1
Transferred to profit or loss
(136)
(136)
Net gains in respect of cash flow hedging
of capital expenditure
10
10
Tax
2
3
1
6
Cash flow hedges transferred to the statement
of financial position, net of tax
5
5
At 1 April 2023
1,306
(61)
(38)
79
19
(5,165)
(3,860)
Exchange adjustments¹
(335)
(335)
Net gains/(losses) taken to equity
16
37
34
87
Transferred to profit or loss
224
(11)
213
Net losses in respect of cash flow hedging
of capital expenditure
(37)
(37)
Tax
(50)
(6)
(4)
(60)
Cash flow hedges transferred to the statement
of financial position, net of tax
2
2
At 31 March 2024
971
94
(18)
109
19
(5,165)
(3,990)
1.The exchange adjustments recorded in the translation reserve comprise a loss of £397 million (2023: gain of £1,080 million; 2022: gain of £754 million) relating to the translation of
foreign operations, offset by a gain of £62 million (2023: loss of £198 million; 2022: loss of £125 million) relating to borrowings, cross-currency swaps and foreign exchange forward
contracts used to hedge the net investment in non-sterling denominated subsidiaries.
2.In the year ended 31 March 2022, the Group disposed of its equity instruments related to shares held as part of a portfolio of financial instruments which back some long‑term employee
liabilities. The equity instruments were previously measured at FVOCI and, prior to the disposal, the Group recognised a gain of £12 million. The accumulated gain of £82 million
recognised in other comprehensive income in the year ended 31 March 2022 was transferred to retained earnings on disposal.